• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS SAPIEN 3 ULTRA RESILIA TRANSCATHETER HEART VALVE; PROSTHESIS, MITRAL VALVE, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS SAPIEN 3 ULTRA RESILIA TRANSCATHETER HEART VALVE; PROSTHESIS, MITRAL VALVE, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9755RSL26A
Device Problem Perivalvular Leak (1457)
Patient Problems Dyspnea (1816); Fatigue (1849)
Event Date 11/04/2022
Event Type  Injury  
Manufacturer Narrative
Investigation is still ongoing.
 
Event Description
As reported by the field clinical specialist (fcs), during a tmvr procedure with a 26mm sapien 3 ultra valve, the patient came back with significant paravalvular leak (pvl) with dyspnea and fatigue.The patient was treated with post dilation using 26 mm commander delivery system.The patient was stable after post dilation.There were no allegations of an edwards device malfunction.
 
Manufacturer Narrative
Correction to h6 based on additional information.The complaint for paravalvular leak was unable to be confirmed due to unavailability of medical record/procedural imagery.A review of the device history record (dhr) review revealed no indication that a manufacturing non-conformance contributed to the complaint.A review of instructions for use (ifu)/training materials revealed no deficiencies.It should be noted that the thv was implanted in native mitral position with mitral annular calcification (mac) for this case.The sapien 3 ultra resilia (s3ur) with the commander delivery system (ds) was indicated for native aortic valve, surgical and transcatheter bioprosthesis aortic valve, surgical bioprosthesis mitral valve and native mitral valve with an annular plasty ring replacement only.So, it was considered an off-label operation.Per the instructions for use (ifu), paravalvular leak (pvl) is a known potential adverse event associated with bioprosthetic heart valves and the transcatheter valve replacement procedure.Paravalvular leak refers to blood flowing through a channel between the structure of the implanted valve and the cardiac tissue, as a result of a lack of appropriate sealing of the valve to the target site.Some pvl is not uncommon post-deployment.Many cases are mild to moderate, and either resolve over time or do not cause symptoms.Others may be more clinically significant and require intervention.The mechanism behind worsening pvl, as reported in this case, is not well understood but may be related to cardiac remodeling.As reported, 'during a tmvr procedure with a 26mm sapien 3 ultra valve, the patient came back with significant paravalvular leak (pvl) with dyspnea and fatigue.The patient was treated with post dilation using 26 mm commander delivery system.The patient was stable after post dilation'.In this case, post-dilation was performed, which indicated deployed valve under expanded.In additional, implanting valve in native mitral annulus could be challenging due to the bicuspid leaflets with non-circular shape of native mitral annulus, which could potentially prevent the pvl skirt to seal against the target site (native annulus), and also restricted valve expansion resulting in paravalvular leak.As such, available information suggests that procedural factors (under expanded valve, off label operation) may have contributed to the complaint event.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.No corrective or preventative actions are required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS SAPIEN 3 ULTRA RESILIA TRANSCATHETER HEART VALVE
Type of Device
PROSTHESIS, MITRAL VALVE, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key15889702
MDR Text Key304589606
Report Number2015691-2022-09567
Device Sequence Number1
Product Code NPU
UDI-Device Identifier00690103215816
UDI-Public(01)00690103215816(17)250803(11)220804219831088
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/30/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number9755RSL26A
Device Catalogue Number9755RSL26A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received01/05/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/04/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-